Clinical trial
Thalidomide With or Without Fludarabine in Treating Patients With Hematologic…
NCT00009984 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00009984 |
|---|---|
| Title | Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer |
| Official title | Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | fludarabine phosphate, thalidomide |
| Enrollment | 70 |
| Start date | Mar 1, 2002 |
| Primary completion | Nov 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: